PRODUCT ANATOMY COACH

Before you operate, you need to know what to cut.

I work with stalled B2C and B2B SaaS products, diagnosing where value leaks and intervening at the root, not on symptoms.

Recurring Symptoms

  • Roadmap that shifts every month
  • Team divided on what really matters
  • Users who try the product but never return
  • Growth driven more by hope than data
  • Always chasing, never leading
  • A team that can’t breathe

SERVICES

Three interventions,
one clear objective.

01

Diagnostic Check-up

4 weeks

  • Analysis of critical product flows
  • North Star metric identification
  • Decision bottleneck mapping

Ideal when something feels off but you can’t pinpoint where.

02

PMF Intervention

8 weeks

  • Redefinition of core user value
  • Structured activation and retention tests
  • Evidence-based product priorities

Ideal when the product exists but can’t generate consistent traction.

03

Product Structuring

12 weeks

  • Product decision framework
  • Clear roles, responsibilities, processes
  • Hiring or reorganization support

Ideal for growing teams at risk of losing direction.

01

Diagnostic Check-up

4 weeks

  • Analysis of critical product flows
  • North Star metric identification
  • Decision bottleneck mapping

Ideal when something feels off but you can’t pinpoint where.

02

PMF Intervention

8 weeks

  • Redefinition of core user value
  • Structured activation and retention tests
  • Evidence-based product priorities

Ideal when the product exists but can’t generate consistent traction.

03

Product Structuring

12 weeks

  • Product decision framework
  • Clear roles, responsibilities, processes
  • Hiring or reorganization support

Ideal for growing teams at risk of losing direction.

CLINICAL OUTCOMES

Measurable results
on real products

Each case describes a real problem, the intervention applied, and the outcome achieved. No generic promises.

High activation, value that is lost in the first 72 hours

Diagnosis

Users completed the initial onboarding but abandoned the product before reaching the first moment of real value.
The roadmap was continually derailed by sales requests and unstructured feedback.

Therapy

  • Identification of the true “first value moment”
  • Simplification of the onboarding flow
  • Team alignment on a primary metric

Outcomes

  • +35% activation on core flow
  • Reduction in early-stage churn
  • Stable and value-oriented roadmap

A complex product without a hierarchy of decisions

Diagnosis

  • The team was building a lot, but without a clear priority.
  • The backlog was growing faster than the impact, slowing down every decision.

Therapy

  • Redefinition of product decision criteria
  • Clarity on what to measure and what to ignore
  • Systematic elimination of low-impact initiatives

Oucomes

  • Reduced and more readable backlog
  • Faster decisions
  • Focus on a few high-value levers

Fragile monetization despite a good acquisition

Diagnosis

  • The product was attracting users, but the transition to paid usage was uncertain.
  • The team was constantly debating whether to add features or change pricing.

Therapy

  • Analysis of real-world active user behavior
  • Alignment between perceived value and pricing structure
  • Rapid testing of upgrade flows

Outcomes

  • Better free → paid conversion
  • Reduction of internal conflicts over priorities
  • Clarity on where the product generates economic value

CLINICAL OUTCOMES

Measurable results
on real products

Each case describes a real problem, the intervention applied,
and the outcome achieved. No generic promises.

Fragile monetization despite good acquisition

Diagnosis

  • The product was attracting users, but upgrade to paid was unreliable.
  • The team debated adding features vs. changing pricing.

Intervention

  • Active user behavior analysis
  • Perceived value and pricing alignment
  • Rapid upgrade flow testing

Outcome

  • Free → Paid conv. ↑
  • Fewer internal priority conflicts
  • Clarity on where the product generates value

A complex product without a hierarchy of decisions

Diagnosis

  • The team was building a lot, but without a clear priority.
  • The backlog was growing faster than the impact, slowing down every decision.

Therapy

  • Redefinition of product decision criteria
  • Clarity on what to measure and what to ignore
  • Systematic elimination of low-impact initiatives

Outcomes

  • Reduced and more readable backlog
  • Faster decisions
  • Focus on a few high-value levers

High activation, value that is lost in the first 72 hours

Diagnosis

Users completed the initial onboarding but abandoned the product before reaching the first moment of real value.
The roadmap was continually derailed by sales requests and unstructured feedback.

Therapy

  • Identification of the true “first value moment”
  • Simplification of the onboarding flow
  • Team alignment on a primary metric

Outcomes

  • +35% activation on core flow
  • Reduction in early-stage churn
  • Stable and value-oriented roadmap

VASCULAR NETWORK

For VCs & Accelerators

Operational de-risking for portfolio companies.
I keep your investments’ circulation healthy.

-40%

PMF Time Reduction

3x

GTM Acceleration

100%

Team Focus

About me

I’ve been working on B2B and B2C digital products for over 14 years, from early-stage startups to funded teams.

My role isn’t to add features or slides, but to identify where the product is lacking value and address those areas.

When I join a project, the expected outcome is clear: stable key metrics, aligned product decisions, and a team that knows what to build and why.

Is this coaching or consulting?

Do I need to have existing users or revenue?

What does the initial diagnosis consist of?

How long does my involvement take?

What is the first concrete step?

Where to intervene matters more than what to build

If your product is stalled, confusing, or fragile,
the priority isn’t building more.
It’s understanding where to intervene.